BCL2 and colorectal carcinoma: BRB treatment resulted in a significant decrease in GRP78 expression, which led to inhibition of the expression of genes involved in CRC migration (c-myc, vimentin, and cytokeratin-encoding genes) and inhibition of the expression of anti-apoptotic proteins Bcl-xl and Bcl-2 [81].